List of Research Studies Utilized
Pharmacologic Approaches to Glycemic Treatment (Chapter 8)
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
- Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets
- New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
- Glycaemic control and hypoglycaemia with new insulin glargine300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study
- Effects of intensive blood-pressure control in type 2 diabetes mellitus
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
- Cardiovascular Outcomes Using Doxazosin vs. Chlorthalidone for the Treatment of Hypertension in Older Adults With and Without Glucose Disorders: A Report From the ALLHAT Study
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
- Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
- Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial
- A randomized controlled study of Finerenone vs. Eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentrer andomised placebo-controlled trial
Cardiovascular Disease and Risk Management (Chapter 9)
NHANES Patient Records
Gender | Age | Ethnicity | Race | Body Mass Index (BMI) | Systolic Blood Pressure (SBP) | Diastolic Blood Pressure (DBP) | HemoglobinA1C (HbA1C) |
---|---|---|---|---|---|---|---|
Male | 55 | NonHispanic | African American | 26.53 | 106 | 72.67 | 5.2 |
Female | 44 | NonHispanic | African American | 30.9 | 139.33 | 73.34 | 6 |
Male | 70 | NonHispanic | White | 24.74 | 130.67 | 57.34 | 7.1 |
Female | 16 | NonHispanic | African American | 16.79 | 118.67 | 50.67 | 4.7 |
Male | 73 | NonHispanic | White | 30.63 | 120 | 67.34 | 5.9 |
Female | 14 | NonHispanic | African American | 34.5 | 114 | 77.34 | 8 |